Preventive therapy for asthma became therapeutically possible when the oral prophylactic drugs cromoglycate and ketotifen were introduced. However, use of drugs which rapidly ameliorate the symptoms of asthma continues to be the predominant treatment. This volume seeks to identify the need for preventive therapy, the options available, methods for clinical evaluation of newer therapies, and possible clinical and economic benefits when anti-asthma therapy is directed towards prevention.
Read More
Preventive therapy for asthma became therapeutically possible when the oral prophylactic drugs cromoglycate and ketotifen were introduced. However, use of drugs which rapidly ameliorate the symptoms of asthma continues to be the predominant treatment. This volume seeks to identify the need for preventive therapy, the options available, methods for clinical evaluation of newer therapies, and possible clinical and economic benefits when anti-asthma therapy is directed towards prevention.
Read Less
